Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Ottawa Marriott Hotel

Oct 30, 2018 7:00 AM - Oct 31, 2018 3:00 PM

100 Kent Street , Ottawa, ON K1P5R7 , CANADA

DIA Annual Canadian Meeting

Transformation with Collaboration

Session 5: Track C: Regulatory Considerations for Small- and Medium-Sized Enterprises

Session Chair(s)

Loretta  Del Bosco

Loretta Del Bosco

Director, Regulatory Affairs Quality Assurance Operations

AbbVie Corporation, Canada

The regulatory landscape in Canada is transforming rapidly. This session will allow for a better understanding of the challenges and opportunities faced by small- and medium-sized enterprises as they navigate the present and most importantly, the future in Canada. Whether you are from a large global or a small/medium-sized company, this session will provide transferable insights.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Identify the regulatory process challenges of small/medium-sized companies
  • Describe how the regulatory revisions currently underway will affect small/medium-sized companies
  • Explain how small/medium-sized companies find opportunities to thrive in a regulated environment


Yatika  Kohli, PhD, MBA

Global R&D at Small Companies - Impact and Benefits of Harmonized Guidelines

Yatika Kohli, PhD, MBA

NoNO Inc, Canada

Chief Regulatory and Strategy Officer

Tammy  Mitchell-Moore

Changes in the Regulatory Environment: Four Pillars of Impact for Small- and Medium-Sized Enterprises

Tammy Mitchell-Moore

Eisai Limited, Canada

Associate Director, Regulatory Affairs

Joe  O’neill

Case Study: Practical Approach for a Small Company as a Product Goes Through the Health Canada Process

Joe O’neill

Accelera Pharma Canada, Canada


Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.